Sunshine Biopharma (SBFM) Retained Earnings (2016 - 2025)
Sunshine Biopharma (SBFM) has disclosed Retained Earnings for 14 consecutive years, with -$320841.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Retained Earnings rose 99.52% year-over-year to -$320841.0, compared with a TTM value of -$320841.0 through Sep 2025, up 99.52%, and an annual FY2024 reading of -$69.0 million, down 8.03% over the prior year.
- Retained Earnings was -$320841.0 for Q3 2025 at Sunshine Biopharma, up from -$72.0 million in the prior quarter.
- Across five years, Retained Earnings topped out at $204549.0 in Q3 2023 and bottomed at -$72.0 million in Q2 2025.
- Average Retained Earnings over 5 years is -$36.1 million, with a median of -$33.3 million recorded in 2021.
- The sharpest move saw Retained Earnings tumbled 871415.09% in 2021, then soared 356.0% in 2023.
- Year by year, Retained Earnings stood at -$32.7 million in 2021, then tumbled by 81.9% to -$59.4 million in 2022, then dropped by 7.59% to -$63.9 million in 2023, then fell by 8.03% to -$69.0 million in 2024, then soared by 99.54% to -$320841.0 in 2025.
- Business Quant data shows Retained Earnings for SBFM at -$320841.0 in Q3 2025, -$72.0 million in Q2 2025, and -$70.2 million in Q1 2025.